Chester County News and Community Website
WYNNEWOOD, PA — A researcher with Main Line Health has secured a U.S. patent for protein fragments that could be used to both detect and prevent Lyme disease, offering hope …
Main Line Health Researcher Patents New Tools To Detect and Prevent Lyme Disease Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced this week that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a new patent …
Madrigal Pharmaceuticals Secures Key Patent for Rezdiffra, Extending Market Protection to 2044 Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the U.S. Patent and Trademark Office has issued a new patent covering its lead investigational therapy, istaroxime, for intravenous treatment …
Windtree Therapeutics Secures U.S. Patent for Istaroxime Heart Failure Treatment Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the issuance of U.S. patent No. 12,329,748 by the United States Patent and Trademark Office (USPTO), providing increased protection for its …
Palvella Therapeutics Secures New Patent for QTORIN™ Rapamycin Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced significant advancements in the intellectual property backing its AVIM (Atrioventricular Interval Modulation) therapy pipeline. Over the past year, …
Orchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough Designation Read More
MALVERN, PA — Rajant Health Incorporated (RHI) has been granted a new patent for its innovative Parallel Adaptive Motion Artifact Removal technology, marking a major advancement in wearable health monitoring …
Rajant Health Secures Patent for Cutting-Edge Wearable Monitoring Technology Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has secured its fifth U.S. patent for QTORIN™ 3.9% rapamycin anhydrous gel, reinforcing its position in the development of treatments for rare …
Palvella Therapeutics Secures New U.S. Patent for QTORIN Rapamycin Read More
PHOENIXVILLE, PA — PleoPharma, Inc. has announced a significant intellectual property milestone with the issuance of its third U.S. patent, aimed at addressing sleep disturbances linked to cannabis withdrawal syndrome …
PleoPharma Secures Patent for Treating Sleep Disturbances in Cannabis Withdrawal Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application number …
Windtree Therapeutics Secures Patent for Istaroxime IV Formulation in Acute Heart Failure Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has been granted a U.S. patent for the use of its leading compound, buntanetap, in the treatment and prevention of acute brain and …
Annovis Bio Secures U.S. Patent for Neuroprotective Drug Buntanetap Read More